136 related articles for article (PubMed ID: 12545824)
1. [An evaluation of adenosine triphosphate bioluminescence assay for tumor in vitro chemosensitivity testing].
Liu S; Peng Z; Lou J; Wang H; Tang Q; He B
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):330-3. PubMed ID: 12545824
[TBL] [Abstract][Full Text] [Related]
2. [Application of spectrophotometry to evaluation of the levels and the influence of chemotherapeutic drugs on ATP of malignant cell lines].
Wang H; Peng Z; Ding S
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):300-3. PubMed ID: 10684039
[TBL] [Abstract][Full Text] [Related]
3. [Comparison between apoptosis cells count and ATP-bioluminescence assay in ovarian cancer chemosensitivity testing in vitro].
Lou J; Wang H; Liu S; Peng Z
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):267-9. PubMed ID: 12575205
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
[TBL] [Abstract][Full Text] [Related]
5. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
Shi W; Gu M; Liang L
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
[TBL] [Abstract][Full Text] [Related]
7. [Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].
Liu S; Qian X; Peng Z; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):298-9, 312. PubMed ID: 12947719
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
O'Meara AT; Sevin BU
Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
[TBL] [Abstract][Full Text] [Related]
9. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
10. [Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer].
Jinushi K; Hirabayashi N; Kirihara Y; Takagami S; Ryuji K; Yorishima T; Nishiyama M; Noso Y; Toge T
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2235-9. PubMed ID: 2122811
[TBL] [Abstract][Full Text] [Related]
11. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
[TBL] [Abstract][Full Text] [Related]
12. Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay.
Gerhardt RT; Perras JP; Sevin BU; Petru E; Ramos R; Guerra L; Averette HE
Am J Obstet Gynecol; 1991 Aug; 165(2):245-55. PubMed ID: 1872324
[TBL] [Abstract][Full Text] [Related]
13. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
14. [Result of individualized chemotherapy with a newly developed in vitro chemosensitivity testing in ovarian cancer].
Iijima N; Sekiya S; Tokita H; Oosaki T; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1323-8. PubMed ID: 1955784
[TBL] [Abstract][Full Text] [Related]
15. [An adenosine triphosphate bioluminescence assay for detecting the number of living cells].
Liu S; Peng Z; Wang H; Lou J; He B; Tang Q; Qiu D
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):260-1, 268. PubMed ID: 12515155
[TBL] [Abstract][Full Text] [Related]
16. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer.
Sevin BU; Perras JP
Am J Obstet Gynecol; 1997 Apr; 176(4):759-66; discussion 766-8. PubMed ID: 9125599
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the in vivo and in vitro chemosensitivity tests using human tumor xenografts].
Yamada Y; Yamada T; Asanuma F; Suzuki T; Kawamura E
Hum Cell; 1995 Dec; 8(4):179-84. PubMed ID: 8721088
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitivity to the new anthracycline pirarubicin and other chemotherapeutic agents in primary and recurrent ovarian tumors in vitro.
Untch M; Sevin BU; Perras JP; Angioli R; Baibl A; Nguyen HN; Hightower RD; Averette HE
Gynecol Oncol; 1992 Nov; 47(2):172-8. PubMed ID: 1468695
[TBL] [Abstract][Full Text] [Related]
20. Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing.
Sevin BU; Peng ZL; Perras JP; Ganjei P; Penalver M; Averette HE
Gynecol Oncol; 1988 Sep; 31(1):191-204. PubMed ID: 3410347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
